Tianshui Zhongxing Bio-technology Co Ltd (002772) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tianshui Zhongxing Bio-technology Co Ltd (002772) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥143.77 Million ≈ $21.04 Million USD) by net assets (CN¥3.40 Billion ≈ $497.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tianshui Zhongxing Bio-technology Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Tianshui Zhongxing Bio-technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 002772 current and long-term liabilities for a breakdown of total debt and financial obligations.
Tianshui Zhongxing Bio-technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tianshui Zhongxing Bio-technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
I.E.S Holdings Ltd
TA:IES
|
0.010x |
|
Alphamin Resources Corp
F:21L
|
N/A |
|
Guangdong Hongtu Technology Holdings Co Ltd
SHE:002101
|
0.023x |
|
Lingda Group Co Ltd
SHE:300125
|
0.033x |
|
ProFrac Holding Corp.
NASDAQ:ACDC
|
0.001x |
|
Amerant Bancorp Inc.
NYSE:AMTB
|
0.024x |
|
Sichuan Zigong Conveying Machine Group Co Ltd
SHE:001288
|
-0.067x |
|
Guangzhou Automobile Group Co. Ltd
F:02G
|
0.001x |
Annual Cash Flow Conversion Efficiency for Tianshui Zhongxing Bio-technology Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Tianshui Zhongxing Bio-technology Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Tianshui Zhongxing Bio-technology Co Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.32 Billion ≈ $485.64 Million |
CN¥494.52 Million ≈ $72.36 Million |
0.149x | -2.40% |
| 2023-12-31 | CN¥3.44 Billion ≈ $502.73 Million |
CN¥524.50 Million ≈ $76.75 Million |
0.153x | +4.67% |
| 2022-12-31 | CN¥3.38 Billion ≈ $495.28 Million |
CN¥493.70 Million ≈ $72.24 Million |
0.146x | +214.63% |
| 2021-12-31 | CN¥3.25 Billion ≈ $475.74 Million |
CN¥-413.68 Million ≈ $-60.53 Million |
-0.127x | -189.30% |
| 2020-12-31 | CN¥2.73 Billion ≈ $399.82 Million |
CN¥389.32 Million ≈ $56.97 Million |
0.142x | +3.24% |
| 2019-12-31 | CN¥2.60 Billion ≈ $380.77 Million |
CN¥359.15 Million ≈ $52.55 Million |
0.138x | +56.76% |
| 2018-12-31 | CN¥2.63 Billion ≈ $385.22 Million |
CN¥231.79 Million ≈ $33.92 Million |
0.088x | +11.89% |
| 2017-12-31 | CN¥2.63 Billion ≈ $385.54 Million |
CN¥207.34 Million ≈ $30.34 Million |
0.079x | -22.70% |
| 2016-12-31 | CN¥2.29 Billion ≈ $335.46 Million |
CN¥233.39 Million ≈ $34.15 Million |
0.102x | -49.54% |
| 2015-12-31 | CN¥1.04 Billion ≈ $151.88 Million |
CN¥209.43 Million ≈ $30.65 Million |
0.202x | -40.99% |
| 2014-12-31 | CN¥498.05 Million ≈ $72.88 Million |
CN¥170.31 Million ≈ $24.92 Million |
0.342x | +49.69% |
| 2013-12-31 | CN¥407.25 Million ≈ $59.59 Million |
CN¥93.03 Million ≈ $13.61 Million |
0.228x | -15.13% |
| 2012-12-31 | CN¥351.30 Million ≈ $51.41 Million |
CN¥94.56 Million ≈ $13.84 Million |
0.269x | -47.48% |
| 2011-12-31 | CN¥181.49 Million ≈ $26.56 Million |
CN¥93.01 Million ≈ $13.61 Million |
0.512x | -- |
About Tianshui Zhongxing Bio-technology Co Ltd
Tianshui Zhongxing Bio-technology Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of edible fungi in China and internationally. It offers flammulina velutipe mushrooms under the Xihuang brand; agaricus bisporus mushrooms under the Zhongxing brand; and cordyceps sinensis mushrooms, as well as packaging boxes for its products. The company also… Read more